Who is next?

Discussion in 'Pfizer' started by anonymous, Sep 21, 2020 at 8:26 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Team 3 last week. Who is next? Derm? Team 1?
     

  2. anonymous

    anonymous Guest

    Derm
     
  3. anonymous

    anonymous Guest

    clog and scrub wearing "hospital reps" who actually only sell in my clinics outside the hospital.
     
  4. anonymous

    anonymous Guest

    You are. Bye!
     
  5. anonymous

    anonymous Guest

    Team 1 is Tan does not get approved. Rumors that ES is cancelling contract early. We are screwed.
     
  6. anonymous

    anonymous Guest

    Why would they cancel early?
     
  7. anonymous

    anonymous Guest


    They have new co promote partner.
     
  8. anonymous

    anonymous Guest

    What product?
     
  9. anonymous

    anonymous Guest


    They say it’s the latest in VTD technology.
     
  10. anonymous

    anonymous Guest

    Six months by either party.
     
  11. anonymous

    anonymous Guest


    VTD? What’s that?
     
  12. anonymous

    anonymous Guest


    It’s a Vaginal Tightening Device.
     
  13. anonymous

    anonymous Guest

    Incorrect. They will expand field force in anticipation of their new liver test.
     
  14. anonymous

    anonymous Guest


    Nah Derm has strongest pipeline at Pfizer. It’s actually only division besides oncology with new products coming out. Getting ready to launch a new drug next year so there will be an additional product besides Eucrisa.
     
  15. anonymous

    anonymous Guest

    Sweet, this is gonna sell BIG!
     
  16. anonymous

    anonymous Guest

    uhhh, you may want to read up on the vaccines division.... 5 products in 5 years and something called covid vaccine....
     
  17. anonymous

    anonymous Guest

    Eucrisa is a failure